CANY
GKOS icon

Caxton Associates (New York)’s Glaukos GKOS Stock Holding History

Caxton Associates (New York)’s Portfolio GKOS Stock Details GKOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-5,172
Closed -$439K – 497
2021
Q2 		$439K Buy
+5,172
New +$425K 0.05% 204
2020
Q2 		– Sell
-7,466
Closed -$230K – 522
2020
Q1 		$230K Buy
+7,466
New +$383K 0.04% 317
2017
Q2 		– Sell
-5,300
Closed -$272K – 505
2017
Q1 		$272K Buy
+5,300
New +$231K ﹤0.01% 359

Other funds holding GKOS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Caxton Associates (New York)'s GKOS Position: Q3 2021 in Review

Caxton Associates (New York) sold out of Glaukos (GKOS) in Q3 2021, closing a stake of 5,172 shares — an estimated $439K sold.

Caxton Associates (New York) first reported a position in GKOS in Q1 2017 and held it in 3 quarters. The position peaked at $439K in Q2 2021. 206 funds tracked by Wall St. Rank hold GKOS as of Q3 2021.

  • Caxton Associates (New York) reported no remaining Glaukos position as of Q3 2021 after selling out during the quarter.
  • Caxton Associates (New York) sold 5,172 Glaukos shares in Q3 2021, an estimated $439K.
  • Caxton Associates (New York) first reported a position in Glaukos in Q1 2017 and held it in 3 quarters.
  • Caxton Associates (New York)'s Glaukos position peaked at $439K in Q2 2021.
  • 206 funds tracked by Wall St. Rank held Glaukos as of Q3 2021.

Based on Caxton Associates (New York)'s 13F filing for Q3 2021, filed 15 Nov 2021.